Axonics, Inc. Overview
Pro stress-test →Axonics is a medical technology company engaged in the development and commercialization of sacral neuromodulation (SNM) systems used to treat patients with overactive bladder, fecal incontinence, and non-obstructive urinary retention. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence.
Strategic Profile
Pro stress-test →The company's proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce symptoms of bladder and bowel dysfunction. Axonics sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally.
Competitive Landscape
Pro stress-test →Axonics competes in the specialized sacral neuromodulation device market alongside established medical device manufacturers. The company's rechargeable implantable technology differentiates it from legacy battery-dependent competitor systems. Main competitors include Medtronic and other neuromodulation device manufacturers offering traditional SNM solutions.
Industry Context
Axonics, Inc. operates in Medical Device / Neuromodulation.
Key facts
Founded: 2013 · Headquarters: Irvine, US · Employees: N/A · Revenue: N/A · Market cap: N/A